Haddy, T. B., Rana, S. R., & Castro, O. (1999). Benign ethnic neutropenia: what is a normal absolute neutrophil count?. Journal of Laboratory and Clinical Medicine, 133(1), 15-22.
Smyth, E. M., Grosser, T., Wang, M., Yu, Y., & FitzGerald, G. A. (2009). Prostanoids in health and disease. Journal of lipid research, 50(Supplement), S423-S428.
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., … & Cheng, Z. (2020). Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet.
Wong, C. K., Lam, C. W. K., Wu, A. K. L., Ip, W. K., Lee, N. L. S., Chan, I. H. S., … & Sung, J. J. Y. (2004). Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome. Clinical & Experimental Immunology, 136(1), 95-103.
Mahallawi, W. H., Khabour, O. F., Zhang, Q., Makhdoum, H. M., & Suliman, B. A. (2018). MERS-CoV infection in humans is associated with a pro-inflammatory Th1 and Th17 cytokine profile. Cytokine, 104, 8-13.
Graham, G. G., Davies, M. J., Day, R. O., Mohamudally, A., & Scott, K. F. (2013). The modern pharmacology of paracetamol: therapeutic actions, mechanism of action, metabolism, toxicity and recent pharmacological findings. Inflammopharmacology, 21(3), 201-232.
Boutaud, O., Aronoff, D. M., Richardson, J. H., Marnett, L. J., & Oates, J. A. (2002). Determinants of the cellular specificity of acetaminophen as an inhibitor of prostaglandin H2 synthases. Proceedings of the National Academy of sciences, 99(10), 7130-7135.
Aronoff, D. M., Oates, J. A., & Boutaud, O. (2006). New insights into the mechanism of action of acetaminophen: its clinical pharmacologic characteristics reflect its inhibition of the two prostaglandin H 2 synthases.
Brzozowski, T., Konturek, P. C., Konturek, S. J., Sliwowski, Z., Pajdo, R., Drozdowicz, D., … & Hahn, E. G. (2001). Classic NSAID and selective cyclooxygenase (COX)‐1 and COX‐2 inhibitors in healing of chronic gastric ulcers. Microscopy research and technique, 53(5), 343-353.
Grosser, T. (2006). The pharmacology of selective inhibition of COX-2. Thrombosis and haemostasis, 96(10), 393-400.